Skip to content

Evaluation of Visual Outcomes After Myopic LASIK

Analysis of Visual Outcomes, Contrast Sensitivity, Glare, Induction of High Order Aberrations and Wavefront Technology, Following LASIK Surgery

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00366743
Enrollment
120
Registered
2006-08-21
Start date
2003-05-31
Completion date
2005-06-30
Last updated
2006-08-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Astigmatism, Myopia, Myopic Astigmatism

Brief summary

The aim of the study was to evaluate visual outcomes, contrast sensitivity, glare testing and high order aberrations induced by different laser technologies and to evaluate differences in aberrometer technology. We hypothesized that there will not be differences among conventional or wavefront guided treatments.

Detailed description

The aim of the study was to evaluate and compare visual outcomes, contrast sensitivity, glare testing and induction of high order aberrations by different laser technologies and to evaluate differences in aberrometer technology.

Interventions

PROCEDUREConventional LASIK

Sponsors

Medical University of South Carolina
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE

Eligibility

Sex/Gender
ALL
Age
21 Years to 60 Years
Healthy volunteers
No

Inclusion criteria

* 18 years or older * Candidates for bilateral LASIK * Myopic range: 0.00 to -7.00 D * Astigmatism: 0.00 to -5.00 D

Exclusion criteria

* Pupil size greater than 8mm diameter, infrared measurement * thin corneas (preoperatively calculated minimal residual bed \< 250 um) * irregular astigmatism * asymmetric astigmatism * unstable refraction * other criteria that preclude the patient to undergo LASIK

Design outcomes

Primary

MeasureTime frame
Visual acuity
Contrast sensitivity
Induction of high order aberrations

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026